TELA Bio, Inc.
NASDAQ:TELA
Overview | Financials
Company Name | TELA Bio, Inc. |
Symbol | TELA |
Currency | USD |
Price | 2.91 |
Market Cap | 114,620,244 |
Dividend Yield | 0% |
52-week-range | 2.3 - 7.84 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Antony Koblish |
Website | https://www.telabio.com |
An error occurred while fetching data.
About TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD